vs
Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and NETSTREIT Corp. (NTST). Click either name above to swap in a different company.
Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $57.1M, roughly 1.2× NETSTREIT Corp.). NETSTREIT Corp. runs the higher net margin — 10.0% vs 4.7%, a 5.3% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 24.3%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 20.1%).
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.
ADPT vs NTST — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $70.9M | $57.1M |
| Net Profit | $3.4M | $5.7M |
| Gross Margin | 73.6% | — |
| Operating Margin | -27.1% | 34.1% |
| Net Margin | 4.7% | 10.0% |
| Revenue YoY | 35.1% | 24.3% |
| Net Profit YoY | — | 235.9% |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $70.9M | $57.1M | ||
| Q4 25 | $71.7M | $52.5M | ||
| Q3 25 | $94.0M | $48.3M | ||
| Q2 25 | $58.9M | $48.3M | ||
| Q1 25 | $52.4M | $45.9M | ||
| Q4 24 | $47.5M | $44.1M | ||
| Q3 24 | $46.4M | $41.4M | ||
| Q2 24 | $43.2M | $39.6M |
| Q1 26 | $3.4M | $5.7M | ||
| Q4 25 | $-13.6M | $1.3M | ||
| Q3 25 | $9.5M | $618.0K | ||
| Q2 25 | $-25.6M | $3.3M | ||
| Q1 25 | $-29.9M | $1.7M | ||
| Q4 24 | $-33.7M | $-5.4M | ||
| Q3 24 | $-32.1M | $-5.3M | ||
| Q2 24 | $-46.2M | $-2.3M |
| Q1 26 | 73.6% | — | ||
| Q4 25 | 74.6% | — | ||
| Q3 25 | 80.7% | — | ||
| Q2 25 | 69.4% | — | ||
| Q1 25 | 67.6% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 64.1% | — | ||
| Q2 24 | 55.3% | — |
| Q1 26 | -27.1% | 34.1% | ||
| Q4 25 | -17.8% | 2.6% | ||
| Q3 25 | 10.9% | 1.3% | ||
| Q2 25 | -42.5% | 6.8% | ||
| Q1 25 | -56.4% | 3.7% | ||
| Q4 24 | -71.3% | -12.3% | ||
| Q3 24 | -70.3% | -12.8% | ||
| Q2 24 | -109.6% | -5.8% |
| Q1 26 | 4.7% | 10.0% | ||
| Q4 25 | -18.9% | 2.5% | ||
| Q3 25 | 10.2% | 1.3% | ||
| Q2 25 | -43.5% | 6.8% | ||
| Q1 25 | -56.9% | 3.7% | ||
| Q4 24 | -71.0% | -12.3% | ||
| Q3 24 | -69.1% | -12.8% | ||
| Q2 24 | -107.0% | -5.8% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $-0.08 | $0.01 | ||
| Q3 25 | $0.06 | $0.01 | ||
| Q2 25 | $-0.17 | $0.04 | ||
| Q1 25 | $-0.20 | $0.02 | ||
| Q4 24 | $-0.22 | $-0.07 | ||
| Q3 24 | $-0.22 | $-0.07 | ||
| Q2 24 | $-0.31 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $1.5B |
| Total Assets | $505.9M | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $77.6M | — | ||
| Q4 25 | $70.5M | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | $43.2M | — | ||
| Q1 25 | $50.6M | — | ||
| Q4 24 | $47.9M | — | ||
| Q3 24 | $38.1M | — | ||
| Q2 24 | $59.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $926.6M | ||
| Q1 25 | — | $913.3M | ||
| Q4 24 | — | $868.3M | ||
| Q3 24 | — | $778.7M | ||
| Q2 24 | — | $726.2M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $218.8M | $1.4B | ||
| Q3 25 | $204.4M | $1.3B | ||
| Q2 25 | $179.7M | $1.3B | ||
| Q1 25 | $190.4M | $1.3B | ||
| Q4 24 | $202.7M | $1.3B | ||
| Q3 24 | $223.8M | $1.3B | ||
| Q2 24 | $241.6M | $1.3B |
| Q1 26 | $505.9M | $2.8B | ||
| Q4 25 | $512.7M | $2.6B | ||
| Q3 25 | $490.6M | $2.5B | ||
| Q2 25 | $496.6M | $2.3B | ||
| Q1 25 | $510.9M | $2.3B | ||
| Q4 24 | $539.4M | $2.3B | ||
| Q3 24 | $558.5M | $2.2B | ||
| Q2 24 | $584.9M | $2.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.84× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADPT
Segment breakdown not available.
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |
